ArticleMucosal immunology2016

Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10.

B Lamarthée et al.PubMed ↗Publisher ↗

No numbers read from the abstract.